Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT05171777
Title	A Study to Evaluate Participant and Healthcare Professional Reported Preference for Subcutaneous Atezolizumab Compared With Intravenous Atezolizumab Formulation in Participants With Non-Small Cell Lung Cancer
Recruitment	Active, not recruiting
Gender	both
Phase	Phase II
Variant Requirements	Yes
Sponsors	Hoffmann-La Roche
Indications	lung non-small cell carcinoma
Therapies	Atezolizumab
Age Groups:	adult \| senior
Covered Countries	USA \| POL \| LVA \| ITA \| FIN \| ESP \| CAN \| BRA \| ARG